Evaluation of IGFBP5 expression and plasma osteopontin level in COVID-19 patients

Azkur, 2020, Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19, Allergy, 75, 1564, 10.1111/all.14364 Wiersinga, 2020, Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19), JAMA, 324, 782, 10.1001/jama.2020.12839 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Zou, 2021, The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT, PLoS One, 16, 10.1371/journal.pone.0248957 Güllü, 2012, Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers, Chin J Cancer, 31, 266, 10.5732/cjc.011.10405 Skarlis, 2019, The role of insulin growth factors in autoimmune diseases, Ann. Res. Hosp, 3, 10, 10.21037/arh.2019.03.02 Firth, 2002, Cellular actions of the insulin-like growth factor binding proteins, Endocr Rev, 23, 824, 10.1210/er.2001-0033 Duan, 2005, Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions, Gen Comp Endocrinol, 142, 44, 10.1016/j.ygcen.2004.12.022 Duan, 2020, Insulin-like growth factor binding protein-5 in physiology and disease, Front Endocrinol, 11, 100, 10.3389/fendo.2020.00100 Pilewski, 2005, Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition, Am J Pathol, 166, 399, 10.1016/S0002-9440(10)62263-8 Nguyen, 2018, IGFBP-5 promotes fibrosis via increasing its own expression and that of other pro-fibrotic mediators, Front Endocrinol, 9, 601, 10.3389/fendo.2018.00601 Yasuoka, 2009, The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration, Am J Respir Cell Mol Biol, 41, 179, 10.1165/rcmb.2008-0211OC Clemente, 2016, Osteopontin bridging innate and adaptive immunity in autoimmune diseases, J. Immunol. Res., 2016, 1, 10.1155/2016/7675437 Uede, 2011, Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases, Pathol Int, 61, 265, 10.1111/j.1440-1827.2011.02649.x Clemente, 2017, Role of anti-osteopontin antibodies in multiple sclerosis and experimental autoimmune encephalomyelitis, Front Immunol, 8, 321, 10.3389/fimmu.2017.00321 Castello, 2019, The role of osteopontin as a diagnostic and prognostic biomarker in sepsis and septic shock, Cells, 8, 174, 10.3390/cells8020174 Varım, 2021, Relationship between serum osteopontin levels and the severity of COVID-19 infection, Wien Klin Wochenschr, 133, 298, 10.1007/s00508-020-01789-5 Takahashi, 2001, Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis, Am J Respir Cell Mol Biol, 24, 264, 10.1165/ajrcmb.24.3.4293 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method, Methods, 25, 402, 10.1006/meth.2001.1262 Lang, 2006, Sepsis and inflammatory insults downregulate IGFBP-5, but not IGFBP-4, in skeletal muscle via a TNF-dependent mechanism, Am J Physiol Regul Integr Comp Physiol, 290, R963, 10.1152/ajpregu.00684.2005 Vastrad, 2020, Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19, Gene Reports, 21, 10.1016/j.genrep.2020.100956 Hayek, 2021, Circulating osteopontin levels and outcomes in patients hospitalized for COVID-19, J Clin Med, 10, 3907 Reisner, 2022, Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: a pilot study, Exp. Biol. Med., 247, 145, 10.1177/15353702211046835 Pardo, 2005, Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis, PLoS Med, 2, e251, 10.1371/journal.pmed.0020251 Nam, 2000, Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-Binding protein-5 leading to an alteration in IGF-I-stimulated cell growth, Endocrinology, 141, 1100, 10.1210/endo.141.3.7386 Kim, 2007, Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells, Biofactors, 29, 187, 10.1002/biof.5520290403 Durant, 2004, Overexpression of insulin-like growth factor binding protein-5 decreases osteoblastic function in vitro, Bone, 35, 1256, 10.1016/j.bone.2004.08.011